Cargando…
Mendelian randomization highlights significant difference and genetic heterogeneity in clinically diagnosed Alzheimer’s disease GWAS and self-report proxy phenotype GWAX
BACKGROUND: Until now, Mendelian randomization (MR) studies have investigated the causal association of risk factors with Alzheimer’s disease (AD) using large-scale AD genome-wide association studies (GWAS), GWAS by proxy (GWAX), and meta-analyses of GWAS and GWAX (GWAS+GWAX) datasets. However, it c...
Autores principales: | Liu, Haijie, Hu, Yang, Zhang, Yan, Zhang, Haihua, Gao, Shan, Wang, Longcai, Wang, Tao, Han, Zhifa, Sun, Bao-liang, Liu, Guiyou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800228/ https://www.ncbi.nlm.nih.gov/pubmed/35090530 http://dx.doi.org/10.1186/s13195-022-00963-3 |
Ejemplares similares
-
Effect of plasma vitamin C levels on Parkinson’s disease and age at onset: a Mendelian randomization study
por: Liu, Haijie, et al.
Publicado: (2021) -
Mendelian randomization to evaluate the effect of plasma vitamin C levels on the risk of Alzheimer’s disease
por: Liu, Haijie, et al.
Publicado: (2021) -
rs1990622 variant associates with Alzheimer’s disease and regulates TMEM106B expression in human brain tissues
por: Hu, Yang, et al.
Publicado: (2021) -
Pervasive biases in proxy GWAS based on parental history of Alzheimer’s disease
por: Wu, Yuchang, et al.
Publicado: (2023) -
Mendelian randomization highlights insomnia as a risk factor for pain diagnoses
por: Broberg, Martin, et al.
Publicado: (2021)